Happily, not much sun exposure is required for many people to meet their vitamin D needs. Ten minutes of sun exposure at a UV ...

The trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it received a delinquency notification letter (the "Notice") from the ...

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

Exploratory outcome measures include health-related quality of life, overall survival, and biomarker assessments. A broad cross-section of geographically and socioeconomically diverse clinical sites ...

INOVIO (NASDAQ: INO) has unveiled promising peer-reviewed results from its Phase 1/2 clinical trial for INO-3107, a ...

Logan Barber turned 12 on Saturday, Feb. 8. He wanted to celebrate this milestone by going out with his family. His chosen ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, ...

UPMC Enterprises, the innovation, commercialization and venture capital arm of Pittsburgh-based UPMC, has developed a virtual environment to evaluate and refine AI models. The virtual environment, ...

Cleveland Clinic’s Travis Tyson discusses the potential of AI and the opportunity to maximize existing building footprints to ...